Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model

INTRODUCTION: Triple-negative breast cancer (TNBC) is a highly aggressive subtype with a poor prognosis. Current single-agent checkpoint therapy has limited effectiveness in TNBC patients. In this study, we developed doxorubicin-loaded platelet decoys (PD@Dox) for chemotherapy and induction of tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hang, Gao, Meng, Lu, Lu, Gui, Rong, Fu, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319348/
https://www.ncbi.nlm.nih.gov/pubmed/37409026
http://dx.doi.org/10.2147/IJN.S403339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319348/
https://www.ncbi.nlm.nih.gov/pubmed/37409026
http://dx.doi.org/10.2147/IJN.S403339

Ejemplares similares